Enveric Biosciences Inc vs Direxion NASDAQ 100 Equal Weighted Index Shares — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Direxion NASDAQ 100 Equal Weighted Index Shares trades at $118.63. The key difference: Direxion NASDAQ 100 Equal Weighted Index Shares is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | QQQE | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $17.40 | $122.72 |
52-Week Low | $1.28 | $96.06 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QQQE trades at $118.63, down 0.49% today, with a bearish technical signal overall despite bullish moving averages. The ETF offers equal-weighted exposure to the Nasdaq-100, reducing concentration risk compared to cap-weighted peers. Recent news highlights its appeal as a defensive alternative amid high market concentration, with SpaceX's upcoming Nasdaq-100 inclusion potentially driving inflows. Key support sits at $117, with resistance at $119-$120.
Outlook remains balanced; QQQE provides diversified growth exposure but faces headwinds from bearish momentum. Opportunities include reduced single-stock risk and potential rebalancing benefits from new index additions. Risks involve underperformance if mega-cap stocks continue leading the market and broader Nasdaq volatility.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →QQQE is an ETF that seeks to track the performance of the NASDAQ-100 Equal Weighted Index. Unlike traditional market-capitalization-weighted indexes, this fund assigns equal weight to each of the 100 non-financial companies in the NASDAQ-100 and rebalances quarterly. This equal-weighting scheme reduces concentration risk in the largest technology companies and increases the fund's exposure to smaller-cap and mid-cap companies within the index, providing a differentiated growth profile.
Read more on QQQE →